摘要 : Primary anticancer therapy is currently accepted as a therapeutic option for patients with early-stage breast cancer. Its objectives are to increase the chance of achieving a conservative surgery and, similar to adjuvant chemother... 展开
作者 | Bozza~C. Osa~E.-O. Puglisi~F. |
---|---|
作者单位 | |
期刊名称 | 《Women’s health 》 |
总页数 | 11 |
语种/中图分类号 | 英语 / R17 |
关键词 | anticancer drugs development chemotherapy early breast cancer endocrine therapy neoadjuvant therapy pathological complete response primary therapy prognosis randomized clinical trials targeted agents |
馆藏号 | N2009EPST0003604 |